Quick Answer
Gain Therapeutics, Inc. reported Total Assets of $22.82 million for fiscal year 2025.
Gain Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $22.82M | +88.2% |
| 2024 | $12.12M | -34.9% |
| 2023 | $18.61M | -22.8% |
| 2022 | $24.10M | -38.2% |
| 2021 | $38.99M | +305.9% |
| 2020 | $9.60M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $10.97M | -23.6% | +11.6% |
| June 30, 2025 | $9.83M | -48.8% | -15.4% |
| March 31, 2025 | $11.62M | -20.3% | -4.1% |
| December 31, 2024 | $12.12M | -34.9% | -15.6% |
| September 30, 2024 | $14.37M | +1.9% | -25.2% |
| June 30, 2024 | $19.20M | +5.1% | +31.7% |
| March 31, 2024 | $14.58M | -31.6% | -21.7% |
| December 31, 2023 | $18.61M | -22.8% | +32.0% |
- Gain Therapeutics, Inc. showed an increase of +88.2% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Gain Therapeutics, Inc.’s total assets has grown by 137.6% (from $9.60 million to $22.82 million).
- The most recent figure is from Gain Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: